+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors for invasive fungal infections in liver transplant recipients



Risk factors for invasive fungal infections in liver transplant recipients



Chinese Medical Journal 125(2): 400




(PDF emailed within 1 workday: $29.90)

Accession: 055581791

Download citation: RISBibTeXText

PMID: 22340581


Related references

Risk factors for early invasive fungal infections in paediatric liver transplant recipients. Mycoses 2018, 2018

Risk factors for invasive fungal infections in liver transplant recipients receiving tacrolimus as primary immunosuppression. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 242, 1996

Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and Risk Factors. Mycopathologia 180(1-2): 43-50, 2016

Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation 87(3): 424-435, 2009

Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes. Pediatric Transplantation 15(5): 465-469, 2012

Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transplant Infectious Disease 4(1): 3-9, 2002

Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients. Mycopathologia 182(5-6): 495-504, 2017

Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. American Journal of Transplantation 6(2): 386-391, 2006

Risk factors for systemic fungal infections in liver transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases 14(5): 375-382, 1995

Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Transplantation Proceedings 44(9): 2682-2685, 2013

Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients. Transplantation 96(6): 573-578, 2013

Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. Journal of Antimicrobial ChemoTherapy 52(5): 813-819, 2003

Risk factors and impact of beta-D glucan on invasive fungal infection for the living donor liver transplant recipients. Tohoku Journal of Experimental Medicine 209(3): 207-215, 2006

Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. American Journal of Transplantation 14(12): 2758-2764, 2015

Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplantation Direct 3(5): E156, 2017